BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026)
BioAge Labs (BIOA) posted Interest & Investment Income of $3.3 million for Q1 2026, down 74.83% sequentially from $13.0 million in Q4 2025, and down 12.01% YoY from $3.7 million in Q1 2025.
BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026) Analysis & Trends
BioAge Labs has reported Interest & Investment Income for 4 years, with the latest figure at $3.3 million in Q1 2026.
- Quarterly Interest & Investment Income fell 12.01% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (up 7423.04% YoY) and the FY2025 annual result came in at $13.1 million, changed N/A from the prior year.
- Interest & Investment Income slipped to $3.3 million in Q1 2026 per BIOA's latest filing, from $13.0 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $13.0 million in Q4 2025 and troughed at -$5.5 million in Q4 2024.
- A 4-year average of $2.2 million and a median of $1.3 million in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income sank 1560.16% in 2024, then soared 334.62% in 2025.
- Over 4 years, Interest & Investment Income stood at $379000.0 in 2023, then tumbled by 1560.16% to -$5.5 million in 2024, then jumped by 334.62% to $13.0 million in 2025, then tumbled by 74.83% to $3.3 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $3.3 million, $13.0 million, and $73000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | BioAge Labs | 447.94 Mn | 447.94 Mn | -14.23 Mn | 3.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.44 Mn |
| Mar 31, 2026 | 3.27 Mn |
| Dec 31, 2025 | 12.98 Mn |
| Sep 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 3.71 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | 499,000.00 |